Nivolumab Improves Survival in Relapsed Mesothelioma ...Middle East

Medscape - News
In the first placebo-controlled phase 3 trial in relapsed mesothelioma, immunotherapy with nivolumab showed a significant improvement in survival. Medscape Medical News

Hence then, the article about nivolumab improves survival in relapsed mesothelioma was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Nivolumab Improves Survival in Relapsed Mesothelioma )

Apple Storegoogle play

Last updated :

Also on site :